Total Payments
$365.03
2024 Payments
$31.77
Companies
12
Transactions
25
Medicare Patients
291
Medicare Billing
$40,300
Payment Breakdown by Category
Food & Beverage$365.03 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $365.03 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $84.33 | 6 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.05 | 4 | $0 (2018) |
| ABBVIE INC. | $31.77 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.17 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $25.45 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $23.77 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $22.94 | 2 | $0 (2018) |
| Lilly USA, LLC | $16.54 | 1 | $0 (2018) |
| Novo Nordisk Inc | $15.99 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $12.46 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.77 | 2 | ABBVIE INC. ($31.77) |
| 2018 | $333.26 | 23 | PFIZER INC. ($84.33) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/22/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/25/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/22/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Central Nervous System | ||||||
| 10/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/24/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/06/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 08/23/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.60 | General |
| 08/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.23 | General |
| 08/17/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR ORAL, XIFAXANIBSD | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/28/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug), RELISTOR ORAL, XIFAXAN | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/15/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 05/09/2018 | Purdue Pharma L.P. | SYMPROIC (Drug) | Food and Beverage | Cash or cash equivalent | $12.32 | General |
| Category: CONSTIPATION | ||||||
| 05/08/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 66 | 66 | $51,897 | $7,882 |
| 2022 | 2 | 156 | 157 | $119,888 | $22,489 |
| 2021 | 3 | 69 | 104 | $50,309 | $9,929 |
Total Patients
291
Total Services
327
Medicare Billing
$40,300
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 55 | $44,495 | $6,919 | 15.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $7,402 | $962.83 | 13.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 106 | 107 | $83,888 | $15,969 | 19.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 50 | 50 | $36,000 | $6,520 | 18.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 28 | $21,980 | $4,350 | 19.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 24 | 59 | $21,240 | $4,187 | 19.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 17 | 17 | $7,089 | $1,392 | 19.6% |
About Dr. Robert Divencenzo, D.O
Dr. Robert Divencenzo, D.O is a Internal Medicine healthcare provider based in Lewiston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467450833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Divencenzo, D.O has received a total of $365.03 in payments from pharmaceutical and medical device companies, with $31.77 received in 2024. These payments were reported across 25 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($365.03).
As a Medicare-enrolled provider, Divencenzo has provided services to 291 Medicare beneficiaries, totaling 327 services with total Medicare billing of $40,300. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lewiston, NY
- Active Since 07/11/2005
- Last Updated 11/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467450833
Products in Payments
- CHANTIX (Drug) $69.93
- TEFLARO (Drug) $31.77
- FARXIGA (Drug) $23.77
- JANUVIA (Drug) $22.94
- STIOLTO (Drug) $22.82
- STIOLTO RESPIMAT (Drug) $22.40
- XIFAXAN (Drug) $20.51
- TRULICITY (Drug) $16.54
- Tresiba (Drug) $15.99
- LYRICA (Drug) $14.40
- BREO (Drug) $12.73
- TRELEGY ELLIPTA (Drug) $12.72
- XARELTO (Drug) $12.46
- SYMPROIC (Drug) $12.32
- AJOVY (Drug) $12.24
- XIFAXANIBSD (Drug) $10.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lewiston
Yahya Hashmi, Md, MD
Internal Medicine — Payments: $10,104
Internal Medicine $10,104
Dr. Philip Sauvageau, M.d, M.D
Internal Medicine — Payments: $6,873
Internal Medicine $6,873
Tai Ho Shin, Md, MD
Internal Medicine — Payments: $6,556
Internal Medicine $6,556
Clinton Morgan, Md, MD
Internal Medicine — Payments: $1,788
Internal Medicine $1,788
Dr. Barbara Davis, Md, MD
Internal Medicine — Payments: $1,696
Internal Medicine $1,696
Patricia Brady, Md, MD
Internal Medicine — Payments: $1,488
Internal Medicine $1,488